COVID-19 December 19, 2020 6:09 pm What to Know About Johnson & Johnson's COVID Vaccine Johnson & Johnson took a big step forward this week as they announced their phase 3 trials are now fully enrolled with 45,000 people. US & World Videos 2:08 Tension grows over campus protests in Boston 2:31 Fallen Billerica Police Sgt. Ian Taylor honored at vigil 2:33 Massive fire destroys Randolph apartment building 2:50 Rally held in Boston in support of Jewish college students 2:39 MIT president calls for shutdown of student encampments
